COLOMA JASON V (Chief Executive Officer) sold 8.5% of their position (32.56K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $847.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/27/2026ACC: 0001676170-26-000007
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-32.56K
Net shares
Net seller
$847.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
32.56K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−4.50K
Price / share
$26.00
Trade value
$117.10K
% of position
1.2%
5/22/2026
381.07K→376.57K
Common Stock
Indirect
Shares
−2.48K
Price / share
$26.00
Trade value
$64.43K
% of position
8.0%
5/22/2026
31K→28.52K
Common Stock
Indirect
Shares
−25.58K
Price / share
$26.02
Trade value
$665.52K
% of position
6.8%
5/26/2026
376.57K→350.99K
Total
Net shares
−32.56K
Net value
-$847.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/22/2026 | S · Sale | −4.50K | $26.00 | $117.10K | 1.2% | 381.07K | 376.57K |
| Common Stock Indirect | 5/22/2026 | S · Sale | −2.48K | $26.00 | $64.43K | 8.0% | 31K | 28.52K |
| Common Stock Indirect | 5/26/2026 | S · Sale | −25.58K | $26.02 | $665.52K | 6.8% | 376.57K | 350.99K |
| Total | −32.56K | -$847.05K | ||||||
Derivative Transactions0
No derivative transactions reported